Kelsey M Flint

Cardiology

AURORA, CO

M.D.

Last researched 4 months ago

Cardiology Internal Medicine

Request CV & rates Schedule a call

About

Kelsey M. Flint, M.D., MSCS, FACC, is a cardiologist specializing in heart failure, practicing with South Denver Cardiology Associates in the Denver area of Colorado. She completed her cardiology training at the University of Colorado and holds board certifications in Internal Medicine, Cardiovascular Disease, and Advanced Heart Failure and Transplant Cardiology. She currently leads and manages the Heart Failure Program at South Denver Cardiology Associates.

Prior to joining that practice, Dr. Flint served as an Assistant Professor of Medicine at the University of Colorado and held a faculty appointment at the Rocky Mountain Regional VA Medical Center, where she cared for patients with heart failure and related cardiac conditions, supervised trainees, and conducted grant-funded research. She is licensed in Colorado.

Hospital affiliations

Credentials

M.D. MD MSCS

Publications

Time delays between fingerstick glucose measurements and correctional insulin administration in the hospital: do they really matter?
Bivalirudin Monitoring Using Dilute Thrombin Time in Pediatric Extracorporeal Membrane Oxygenation: Single-Center, Retrospective Cost Analysis, 2018-2023.
Dnmt3a-dependent de novo DNA methylation enforces lineage commitment and preserves functionality of memory Th1 and Tfh cells.
Understanding Glycemia in the Post Discharge Period Through Blinded Continuous Glucose Monitoring.
Inpatient Diet Orders and Continuous Glucose Monitoring in Noncritically Ill, Hospitalized Adult Patients.
Fluid requirements for adult inpatients with medically compromised eating disorders: A scoping review.
Vapor-Assisted Mechanochemical Synthesis of Enzyme and Hydrogen-Bonded Organic Framework Biocomposites.
Expanding Access to Continuous Glucose Monitoring in Medicare Patients Receiving Specialty Diabetes Care: A Quality Improvement Project.
The Association of Continuous Glucose Monitoring Metrics with Hospital-Related Clinical Outcomes in Nonintensive Care Units.
Shp-1 regulates the activity of low-affinity T cells specific to endogenous self-antigen during melanoma tumor growth and drives resistance to immune checkpoint inhibition.